<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(1)</volume><submitter>Cao Q</submitter><pubmed_abstract>Epigenetic modifications, particularly DNA methylation, play a critical role in the metastatic progression of breast cancer. This study investigates the role of DNA methyltransferase 1 (DNMT1) in regulating the methylation of RASSF1A and its contribution to breast cancer brain metastasis. Using single-cell transcriptome sequencing of CTCs derived from in situ breast cancer models, DNMT1 was identified as a key promoter of tumor cell viability, migration, and invasion. RASSF1A was further validated as a direct target of DNMT1-mediated methylation. This regulatory interaction was confirmed through DNA methylation sequencing, methylation-specific PCR, and chromatin immunoprecipitation assays. These findings highlight the pivotal role of DNMT1-driven RASSF1A methylation in facilitating breast </pubmed_abstract><journal>Cell death &amp; disease</journal><pagination>80</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12830775</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>DNMT1 modulation of RASSF1A methylation enhances breast cancer brain metastasis.</pubmed_title><pmcid>PMC12830775</pmcid><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Huang G</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Xu G</pubmed_authors><pubmed_authors>Cao Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>DNMT1 modulation of RASSF1A methylation enhances breast cancer brain metastasis.</name><description>Epigenetic modifications, particularly DNA methylation, play a critical role in the metastatic progression of breast cancer. This study investigates the role of DNA methyltransferase 1 (DNMT1) in regulating the methylation of RASSF1A and its contribution to breast cancer brain metastasis. Using single-cell transcriptome sequencing of CTCs derived from in situ breast cancer models, DNMT1 was identified as a key promoter of tumor cell viability, migration, and invasion. RASSF1A was further validated as a direct target of DNMT1-mediated methylation. This regulatory interaction was confirmed through DNA methylation sequencing, methylation-specific PCR, and chromatin immunoprecipitation assays. These findings highlight the pivotal role of DNMT1-driven RASSF1A methylation in facilitating breast </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T20:13:32.421Z</modification><creation>2026-06-04T03:14:00.505Z</creation></dates><accession>S-EPMC12830775</accession><cross_references><pubmed>41381440</pubmed><doi>10.1038/s41419-025-08167-x</doi></cross_references></HashMap>